GlassScriptPhysician profile
Vicki L Chamberlain
NPI 1538155650
$2,063.01
in general payments reported to CMS, 2019-2025
28 companies · $493 in 2025
The $493 reported for 2025 was more than what 79% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $89.87 · 2021: $11.53 · 2022: $75.24 · 2023: $335 · 2024: $650 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,477.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $543.42 | 2019-2025 | Evenity, Prolia |
| Abbvie INC. | $316.03 | 2019-2025 | Liletta, Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $165.94 | 2019-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Mayne Pharma Commercial LLC | $127.38 | 2021-2025 | |
| Shield Therapeutics INC | $80.00 | 2024 | |
| Organon LLC | $79.24 | 2024 | |
| Coopersurgical, INC. | $75.52 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $58.29 | 2025 | Veozah |
| Merck Sharp & Dohme LLC | $55.72 | 2019-2024 | Gardasil 9, Gardasil |
| Sumitomo Pharma America, INC. | $55.60 | 2024 | Myfembree |
| Pfizer INC. | $44.51 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.59 | 2019 | |
| Roche Diagnostics Corporation | $43.17 | 2019 | |
| Biogen, INC. | $39.73 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $39.44 | 2024-2025 | Cologuard Collection Kit |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $38.49 | 2019 | |
| Dysis Medical, INC. | $37.45 | 2019-2020 | |
| Exeltis, USA INC. | $35.87 | 2024-2025 | Slynd |
| Becton, Dickinson and Company | $32.66 | 2023 | Bd Max System, Bd Max Instrument |
| Allergan, INC. | $25.10 | 2019 | |
| Davol INC. | $24.51 | 2019 | |
| Radius Health, INC. | $21.82 | 2023 | Tymlos |
| Acessa Health INC. | $15.19 | 2020 | |
| Minerva Surgical, INC | $14.35 | 2023 | |
| Vertical Pharmaceuticals, LLC | $13.75 | 2019 | |
| Duchesnay USA Incorporated | $12.69 | 2019 | |
| Boston Scientific Corporation | $12.64 | 2019 | |
| Covidien LP | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicki Chamberlain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.